InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Hubbard John W, Director. Insider active across 2 companies, notably Agile Therapeutics INC. Aggregated, 7 filings have been logged. History available since 8 June 2021. The latest transaction was disclosed on 26 August 2024 (Disposition). Regulator: SEC (Form 4). All data is free.
Declarations7 total
976 shares@ US$1.52100.0% of flowCommon StockSEC:0001104659-24-092933:0
2,050 shares@ US$5.75100.0% of flowCommon StockSEC:0001819113-24-000016:0
935 shares0Common StockSEC:0000929638-23-001710:0
40,983 shares0Common StockSEC:0001819113-23-000045:0
670 shares0Common StockSEC:0001104659-22-070178:0
24,510 shares0Common StockSEC:0001104659-21-079620
24,510 shares0Common StockSEC:0001104659-21-079620:0
7 of 7 declarations
About Hubbard John W
John W. Hubbard is a Director at Agile Therapeutics Inc, a biopharmaceutical company. In this role, he participates in the governance of the company and the development of its strategy. Hubbard brings valuable expertise in healthcare, allowing him to play an active role in strategic decision-making. His commitment to innovation and improving healthcare is central to his mission on the board.
